BOGDAN DEACONU: Open Payments
NPI 1932817558 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 44 payments from 13 companies in 2025. Trend: 2023 $13 · 2024 $317 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $223 |
| Amgen Inc. | 9 | $140 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $135 |
| PFIZER INC. | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Esperion Therapeutics, Inc. | 3 | $46 |
| Boston Scientific Corporation | 1 | $38 |
| Edwards Lifesciences Corporation | 1 | $36 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $27 |
Products named: LEQVIO, REPATHA, LifeVest, VYNDAQEL, JARDIANCE, NEXLETOL, WATCHMAN FLX, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve.
Industry payments across MI — which companies pay providers there.
